This website uses cookies. By continuing you are agreeing to our privacy policy.

David J. Lederer, M.D.

Scientific Advisory Committee

Medical Director, Clinical Sciences, Respiratory and Inflammation at Regeneron Pharmaceuticals, Inc.

Dr. Lederer is a pulmonologist and Medical Director at Regeneron Pharmaceuticals where he leads clinical trials in advanced lung diseases. Prior to joining Regeneron, he was an Associate Professor of Medicine and Epidemiology at Columbia University Medical Center in New York, where he led an NHLBI-funded clinical and epidemiological research program. His research included the development of a novel method of measuring early lung inflammation and extracellular matrix remodeling detected years before the onset of pulmonary fibrosis using quantitative CT imaging. He also led the NHLBI-funded Lung Transplant Body Composition study which identified obesity, sarcopenia, and frailty as clinically relevant body composition phenotypes in adults with advanced lung disease. Dr. Lederer was previously the Editor-in-Chief of the Annals of the American Thoracic Society. After serving as a Senior Medical Advisor for the Pulmonary Fibrosis Foundation for 5 years, Dr. Lederer is now a member of the Foundation’s Medical and Scientific Advisory Board.

Red button with telephone
Ask An Expert

Questions about your lung health? Need help finding healthcare? Call 1-800-LUNGUSA.

Get help
Red button of two hand prints
We need your generous support

Make a difference by delivering research, education and advocacy to those impacted by lung disease.

Button of turquoise LUNG FORCE swirl
What is LUNG FORCE?

LUNG FORCE unites women and their loved ones across the country to stand together in the fight against lung cancer.

Get involved
Join the fight for healthy lungs and healthy air.
Donate Now.